194 related articles for article (PubMed ID: 31302815)
61. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
62. Lineage of origin in rhabdomyosarcoma informs pharmacological response.
Abraham J; Nuñez-Álvarez Y; Hettmer S; Carrió E; Chen HI; Nishijo K; Huang ET; Prajapati SI; Walker RL; Davis S; Rebeles J; Wiebush H; McCleish AT; Hampton ST; Bjornson CR; Brack AS; Wagers AJ; Rando TA; Capecchi MR; Marini FC; Ehler BR; Zarzabal LA; Goros MW; Michalek JE; Meltzer PS; Langenau DM; LeGallo RD; Mansoor A; Chen Y; Suelves M; Rubin BP; Keller C
Genes Dev; 2014 Jul; 28(14):1578-91. PubMed ID: 25030697
[TBL] [Abstract][Full Text] [Related]
63. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
Zhang Y; Wang C
Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212
[TBL] [Abstract][Full Text] [Related]
64. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
[TBL] [Abstract][Full Text] [Related]
65. Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis.
Stenman A; Murtha T; Korah R; Carling T
Horm Metab Res; 2017 Aug; 49(8):631-637. PubMed ID: 28641336
[TBL] [Abstract][Full Text] [Related]
66. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
67. A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.
Boudjadi S; Pandey PR; Chatterjee B; Nguyen TH; Sun W; Barr FG
Cancer Res; 2021 Jun; 81(11):2930-2942. PubMed ID: 33589519
[TBL] [Abstract][Full Text] [Related]
68. Fusion gene addiction: can tumours be forced to give up the habit?
Selfe JL; Shipley J
J Pathol; 2017 Jul; 242(3):263-266. PubMed ID: 28378394
[TBL] [Abstract][Full Text] [Related]
69. Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.
Tang G; Liu D; Xiao G; Liu Q; Yuan J
Oncotarget; 2016 Dec; 7(49):81757-81767. PubMed ID: 27835585
[TBL] [Abstract][Full Text] [Related]
70. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
71. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
[TBL] [Abstract][Full Text] [Related]
72. FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells.
Gao Z; Liu R; Ye N; Liu C; Li X; Guo X; Zhang Z; Li X; Yao Y; Jiang X
Cell Physiol Biochem; 2018; 48(1):138-148. PubMed ID: 30001537
[TBL] [Abstract][Full Text] [Related]
73. FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.
Liu L; Yi J; Yuan J; Yao T; Lin Z; Ning Y; Zeng Z
Cancer Biomark; 2020; 28(1):1-8. PubMed ID: 32224523
[TBL] [Abstract][Full Text] [Related]
74. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
[TBL] [Abstract][Full Text] [Related]
75. Anti‑tumor properties of FoxO1 in YD‑9 oral squamous cell carcinoma cells.
Kim YG; Seong C; Cho KA; Lee SM; Kim TJ; Kim HJ; Cho JH; Jung W; Jang S; Shin JC; Lee KH; Byun JS; Kim DY
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144504
[TBL] [Abstract][Full Text] [Related]
76. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.
Olanich ME; Barr FG
Expert Opin Ther Targets; 2013 May; 17(5):607-23. PubMed ID: 23432728
[TBL] [Abstract][Full Text] [Related]
77. Forkhead box protein O1 mediates apoptosis in a cancer cervical cell line treated with the antitumor agent tumor necrosis factor-α.
Zhang B; Gui L; Zhu L; Zhao X; Yang Y; Li Q
Genet Mol Res; 2015 Jul; 14(3):7446-54. PubMed ID: 26214423
[TBL] [Abstract][Full Text] [Related]
78. FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated m
Tan L; Wang S; Huang S; Tie Y; Sai N; Mao Y; Zhao S; Hou Y; Dou H
Cancer Sci; 2024 Apr; 115(4):1224-1240. PubMed ID: 38403332
[TBL] [Abstract][Full Text] [Related]
79. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
[TBL] [Abstract][Full Text] [Related]
80. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
